medigraphic.com
ISSN 3061-8142 (Electronic)
ISSN 0484-7903 (Print)

2019, Number S1

<< Back Next >>

Rev Mex Anest 2019; 42 (S1)

Update in the diagnosis and management of preeclampsia and hypertensive disorders of pregnancy

Smith KA

Language: English
References: 24
Page: 277-280
PDF size: 110.42 Kb.


Text Extraction

Preeclampsia, a disease unique to human pregnancy, affects 2-8% of pregnancies and is one of the leading causes of maternal and neonatal morbidity and mortality(1). Maternal risks include eclampsia, placental abruption, pulmonary edema, renal failure, stroke and death. Fetal risk includes growth restriction, oligohydramnios, intrauterine death and prematurity. It remains unclear why some women develop preeclampsia. Most cases of preeclampsia occur in primiparous patients with no known risk factors.


REFERENCES

  1. ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet Gynecol. 2019;133:211-214.

  2. Creanga A. Maternal mortality in the United States: a review of contemporary data and their limitations. Clin Obstet Gynecol. 2018;61:296-306.

  3. WHO Department of Reproductive Health and Research. (www.who. int/reproductivehealth).

  4. Shields LE, et al. Use of Maternal early warning trigger tool reduces maternal morbidity. Am J Obstet Gynecol. 2016;214:527.e1-527.e6.

  5. Gupta M, Greene N, Kilpatrick SJ. Timely treatment of severe maternal hypertension and reduction in severe maternal morbidity. Pregnancy Hypertens. 2018;14:55-58.

  6. American College of Obstetricians and Gynecologists. Task force on hypertension in pregnancy. Hypertension in pregnancy. Obstet Gynecol. 2013;122:1122-1131.

  7. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol. 2003;102:181-192.

  8. Dean C, DouglasM J. Magnesium and the obstetric anaesthetist. Int J Obstet Anesth. 2013;22:255-256.

  9. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA; Paris Collaborative Group. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet. 2007;369:1765-1766.

  10. LeFevre ML; Preventative Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;161:819-826.

  11. Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. AJOG. 2013;209:544.e1-544.e12.

  12. Valensise H, et al. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008;52:873-880.

  13. Koopmans CM, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374:979-988.

  14. Broekhuijsen K, et al, Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet. 2015;385:2492–501.

  15. Grobman WA, et al. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med. 2018;379:513-523.

  16. McDermott M, et al. Preeclampsia association with posterior reversible encephalopathy syndrome and stroke. Stroke. 2018;49:524-530.

  17. Martin JN, et al. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol. 2005;105:246-254.

  18. Bernstein PS, et al. National partnership for maternal safety consensus bundle on severe hypertension during pregnancy and the postpartum period. Obstetrics and Gynecology. 2017;130.

  19. Levy N, et al. Neuraxial block for delivery among women with low platelet counts: a retrospective analysis. Int J Obstet Anesth. 2018;35:4-9.13.

  20. Aya AG, et al. Spinal anesthesia-induced hypotension: a risk comparison between patients with severe preeclampsia and healthy women undergoing preterm cesarean delivery. Anesth Analg. 2005;101:869-875.

  21. Visalyaputra S, et al. Spinal versus epidural anesthesia for cesarean delivery in severe preeclampsia: a prospective randomized, multicenter study. Anesth Analg. 2005 Sep;101:862-868.

  22. Loureiro L, et al. Diffusion imaging may predict reversible brain lesions in eclampsia and severe preeclampsia: initial experience. Am J Obstet Gynecol. 2003;189:1350-1355.

  23. Pant M, Fong R, Scavone B. Prevention of peri-induction hypertension in preeclamptic patients: a focused review. Anesth Analg. 2014;119:1350-1356.

  24. Bokslag A, Teunissen PW, Franssen C, et al. Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life. Am J Obstet Gynecol. 2017;216:523.e1-7.




2020     |     www.medigraphic.com